A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Name: A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Published: 2019
License: Public Domain

Galecto Biotech AB · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

idiopathic-pulmonary-fibrosis

idiopathic pulmonary fibrosis (ipf), td139, idiopathic pulmonary fibrosis, galectin-3 inhibitor, gb0139, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Related documents